Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelines

References

• American-Psychiatric-Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®) Arlington, VA: American Psychiatric Publishing doi:10.1176/appi.books.9780890425596.
   Google Scholar
• Benkert, O., & Hippius, H. (2017). Kompendium der psychiatrischen Pharmakotherapie. Berlin Heidelberg: Springer-Verlag.
   Google Scholar
• Black, D. W., Blum, N., Pfohl, B., & Hale, N. (2004). Suicidal behavior in borderline personality disorder: prevalence, risk factors, prediction, and prevention. Journal of Personality Disorders, 18, 226–239. doi:10.1521/pedi.18.3.226.35445
   PubMed Web of Science ®Google Scholar
• Bridler, R., Häberle, A., Müller, S. T., Cattapan, K., Grohmann, R., Toto, S., … Greil, W. (2015). Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders. European Journal of Neuropsychopharmacology, 25, 763–772. doi:10.1016/j.euroneuro.2015.03.017
   PubMed Web of Science ®Google Scholar
• Bullinger, M., Kirchberger, I., & Ware, J. (1995). Der deutsche SF-36 Health Survey. Übersetzung und psychometrische Testung eines krankheitsübergreifenden Instruments zur Erfassung der gesundheitsbezogenen Lebensqualität. Journal of Public Health, 3, 21. doi:10.1007/BF02959944
   Google Scholar
• CBO. (2008). Dutch Multidisciplinary Guideline for the diagnosis and treatment of personality disorders. Utrecht, The Netherlands: Trimbos-instituut.
   Google Scholar
• Cohen, J. (1988). Statistical power analysis for the behavioral sciences (Vol. 2). Hillsdale, NJ: Erlbaum Associates.
   Google Scholar
• Coid, J., Yang, M., Tyrer, P., Roberts, A., & Ullrich, S. (2006). Prevalence and correlates of personality disorder in Great Britain. The British Journal of Psychiatry: The Journal of Mental Science, 188, 423–431. doi:10.1192/bjp.188.5.423
   PubMed Web of Science ®Google Scholar
• Coulston, C. M., Tanious, M., Mulder, R. T., Porter, R. J., & Malhi, G. S. (2012). Bordering on bipolar: the overlap between borderline personality and bipolarity. Australian & New Zealand Journal of Psychiatry, 46, 506–521. doi:10.1177/0004867412445528
   PubMed Web of Science ®Google Scholar
• Cuthbert, B. N. (2014). The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry, 13, 28–35. doi:10.1002/wps.20087
   PubMed Web of Science ®Google Scholar
• Davids, E., Bunk, C., Specka, M., & Gastpar, M. (2006). Psychotropic drug prescription in a psychiatric university hospital in Germany. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30, 1109–1116. doi:10.1016/j.pnpbp.2006.04.015
   PubMed Web of Science ®Google Scholar
• Dilling, H., Mombour, W., Schmidt, M. H., & Organization, W. H. (2011). Internationale Klassifikation psychischer Sto¨rungen: ICD-10, Kapitel V (F, klinisch-diagnostische Leitlinien). Bern, Switzerland: Hans Huber.
   Google Scholar
• El-Gabalawy, R., Katz, L. Y., & Sareen, J. (2010). Comorbidity and associated severity of borderline personality disorder and physical health conditions in a nationally representative sample. Psychosomatic Medicine, 72, 641–647. doi:10.1097/PSY.0b013e3181e10c7b
   PubMed Web of Science ®Google Scholar
• Franke, G. H., & Derogatis, L. R. (1995). Die Symptom-Checkliste von Derogatis-Deutsche Version Göttingen, Germany: Beltz.
   Google Scholar
• Frankenburg, F. R., & Zanarini, M. C. (2004). The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. The Journal of Clinical Psychiatry, 65, 1660–1665. doi:10.4088/JCP.v65n1211
   PubMed Web of Science ®Google Scholar
• Frankenburg, F. R., & Zanarini, M. C. (2006). Personality disorders and medical comorbidity. Current Opinion in Psychiatry, 19, 428–431. doi:10.1097/01.yco.0000228766.33356.44
   PubMed Web of Science ®Google Scholar
• Grant, B. F., Chou, S. P., Goldstein, R. B., Huang, B., Stinson, F. S., Saha, T. D., … Ruan, W. J. (2008). Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry, 69, 533. doi:10.4088/JCP.v69n0404
   PubMed Web of Science ®Google Scholar
• Gross, R., Olfson, M., Gameroff, M., Shea, S., Feder, A., Fuentes, M., … Weissman, M. M. (2002). Borderline personality disorder in primary care. Archives of Internal Medicine, 162, 53–60. doi:10.1001/archinte.162.1.53
   PubMed Web of Science ®Google Scholar
• Gunderson, J. G., Stout, R. L., McGlashan, T. H., Shea, M. T., Morey, L. C., Grilo, C. M., … Skodol, A. E. (2011). Ten-year course of borderline personality disorder: Psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Archives of General Psychiatry, 68, 827–837. doi:10.1001/archgenpsychiatry.2011.37
   PubMed Web of Science ®Google Scholar
• Haw, C., & Stubbs, J. (2011). Medication for borderline personality disorder: a survey at a secure hospital. International Journal of Psychiatry in Clinical Practice, 15, 270–274. doi:10.3109/13651501.2011.590211
   PubMed Web of Science ®Google Scholar
• Herpertz, S. C. (2011). Was bringt das DSM-V Neues zur Klassifikation der Persönlichkeitsstörungen?. Zeitschrift Für Psychiatrie, Psychologie Und Psychotherapie, 59, 261–266. doi:10.1024/1661-4747/a000080
   Google Scholar
• Herpertz, S. C., Bohus, M., & Buchheim, P. (2008). S2-Leitlinien Persönlichkeitsstörungen. Retrieved from https://www.dgppn.de/_Resources/Persistent/b642eee188e70d80f260400da7417915d931105d/s2-LL-persoenlichkeitsstoerungen.pdf
   Google Scholar
• Herpertz, S. C., Zanarini, M., Schulz, C. S., Siever, L., Lieb, K., Möller, H.-J., & Wfsbp Task Force On Personality, D. (2007). World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for biological treatment of personality disorders. The World Journal of Biological Psychiatry, 8, 212–244. doi:10.1080/15622970701685224
   PubMed Web of Science ®Google Scholar
• Horowitz, L. M., Strauß, B., & Kordy, H. (1994). IIP-D. Inventar zur Erfassung interpersonaler Probleme. Deutsche Version. Göttingen, Germany: Beltz.
   Google Scholar
• Hörz, S., Zanarini, M. C., Frankenburg, F. R., Reich, D. B., & Fitzmaurice, G. (2010). Ten-year use of mental health services by patients with borderline personality disorder and with other axis II disorders. Psychiatric Services, 61, 612–616. doi:10.1176/ps.2010.61.6.612
   PubMed Web of Science ®Google Scholar
• Ingenhoven, T. J. (2015). Pharmacotherapy for borderline patients: business as usual or by default?. The Journal of Clinical Psychiatry, 76, 522–523.
   PubMed Web of Science ®Google Scholar
• Ingenhoven, T. J., & Duivenvoorden, H. J. (2011). Differential effectiveness of antipsychotics in borderline personality disorder: meta-analyses of placebo-controlled, randomized clinical trials on symptomatic outcome domains. Journal of Clinical Psychopharmacology, 31, 489–496. doi:10.1097/JCP.0b013e3182217a69
   PubMed Web of Science ®Google Scholar
• Ingenhoven, T. J., Lafay, P., Rinne, T., Passchier, J., & Duivenvoorden, H. (2010). Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. The Journal of Clinical Psychiatry, 71, 14–25. doi:10.4088/JCP.08r04526gre)
   PubMed Web of Science ®Google Scholar
• Knoblich, N., Gundel, F., Brückmann, C., Becker-Sadzio, J., Frischholz, C., & Nieratschker, V. (2018). DNA methylation of APBA3 and MCF2 in borderline personality disorder: Potential biomarkers for response to psychotherapy. European Neuropsychopharmacology, 28, 252–263. doi:10.1016/j.euroneuro.2017.12.010
   PubMed Web of Science ®Google Scholar
• Korzekwa, M. I., Dell, P. F., Links, P. S., Thabane, L., & Webb, S. P. (2008). Estimating the prevalence of borderline personality disorder in psychiatric outpatients using a two-phase procedure. Comprehensive Psychiatry, 49, 380–386. doi:10.1016/j.comppsych.2008.01.007
   PubMed Web of Science ®Google Scholar
• Kroeze, W. K., & Roth, B. L. (2012). Polypharmacological drugs: “Magic Shotguns” for psychiatric diseases. In J. Peters (Ed.), Polypharmacology in drug discovery (pp. 133–148). Hoboken, NJ: Wiley.
   Google Scholar
• Lakens, D. (2013). Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol, 4, 863. doi:10.3389/fpsyg.2013.00863
   PubMed Web of Science ®Google Scholar
• Lenzenweger, M. F. (2008). Epidemiology of personality disorders. Psychiatric Clinics of North America, 31, 395–403, vi. doi:10.1016/j.psc.2008.03.003
   PubMed Web of Science ®Google Scholar
• Lieb, K., Vollm, B., Rucker, G., Timmer, A., & Stoffers, J. M. (2010). Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. British Journal of Psychiatry, 196, 4–12. doi:10.1192/bjp.bp.108.062984
   PubMed Web of Science ®Google Scholar
• Loranger, A. W., Sartorius, N., Andreoli, A., Berger, P., Buchheim, P., Channabasavanna, S., … Ferguson, B. (1994). The international personality disorder examination: The World Health Organization/Alcohol, Drug Abuse, and Mental Health Administration international pilot study of personality disorders. Archives of General Psychiatry, 51, 215–224. doi:10.1001/archpsyc.1994.03950030051005
   PubMed Web of Science ®Google Scholar
• Matthies, S. D., & Philipsen, A. (2014). Common ground in attention deficit hyperactivity disorder (ADHD) and borderline personality disorder (BPD)–review of recent findings. Borderline Personality Disorder and Emotion Dysregulation, 1, 3. doi:10.1186/2051-6673-1-3
   PubMedGoogle Scholar
• McGirr, A., Paris, J., Lesage, A., Renaud, J., & Turecki, G. (2009). An examination of DSM-IV borderline personality disorder symptoms and risk for death by suicide: a psychological autopsy study. The Canadian Journal of Psychiatry, 54, 87–92. doi:10.1177/070674370905400206
   PubMed Web of Science ®Google Scholar
• Mercer, D., Douglass, A. B., & Links, P. S. (2009). Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. Journal of Personality Disorders, 23, 156–174. doi:10.1521/pedi.2009.23.2.156
   PubMed Web of Science ®Google Scholar
• National-Collaborating-Centre-for-Mental-Health. (2009). Borderline personality disorder: Treatment and management. Retrieved from https://www.nice.org.uk/guidance/cg78/evidence/bpd-full-guideline-pdf-242147197
   Google Scholar
• National-Health-and-Medical-Research-Council. (2012). Clinical practice guideline for the management of borderline personality disorder. Retrieved from https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/mh25_borderline_personality_guideline.pdf
   Google Scholar
• Nelson, K. J., & Schulz, S. C. (2012). Treatment advances in borderline personality disorder. Psychiatric Annals, 42, 59–64. doi:10.3928/00485713-20120124-06
   Web of Science ®Google Scholar
• Nemeroff, C. B. (2014). Polypharmacology in psychiatry: Good or bad? CNS Spectrums, 3, 19–19. doi:10.1017/S1092852900005800
   Google Scholar
• Oldham, J. M. (2005). Guideline watch: practice guideline for the treatment of patients with borderline personality disorder. FOCUS, 3, 396–400. doi:10.1176/foc.3.3.396
   Google Scholar
• Oldham, J. M., Gabbard, G. O., Goin, M. K., Gunderson, J. G., Soloff, P., Spiegel, D., … Phillips, K. A. (2001). Practice guideline for the treatment of patients with borderline personality disorder. The American Journal of Psychiatry, 158, 1–52. Retrieved from http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/bpd.pdf
   Web of Science ®Google Scholar
• Olejnik, S., & Algina, J. (2003). Generalized eta and omega squared statistics: measures of effect size for some common research designs. Psychol Methods, 8, 434–447. doi:10.1037/1082-989X.8.4.434
   PubMed Web of Science ®Google Scholar
• Pagura, J., Stein, M. B., Bolton, J. M., Cox, B. J., Grant, B., & Sareen, J. (2010). Comorbidity of borderline personality disorder and posttraumatic stress disorder in the U.S. population. Journal of Psychiatric Research, 44, 1190–1198. doi:10.1016/j.jpsychires.2010.04.016
   PubMed Web of Science ®Google Scholar
• Paolini, E., Mezzetti, F. A. F., Pierri, F., & Moretti, P. (2017). Pharmacological treatment of borderline personality disorder: a retrospective observational study at inpatient unit in Italy. International Journal of Psychiatry in Clinical Practice, 21, 75–79. doi:10.1080/13651501.2016.1235202
   PubMed Web of Science ®Google Scholar
• Paton, C., Crawford, M. J., Bhatti, S. F., Patel, M. X., & Barnes, T. R. (2015). The use of psychotropic medication in patients with emotionally unstable personality disorder under the care of UK mental health services. The Journal of Clinical Psychiatry, 76, 512–518. doi:10.4088/JCP.14m09228
   PubMed Web of Science ®Google Scholar
• Peters, J.U. (2013). Polypharmacology – foe or friend?. Journal of Medicinal Chemistry, 56, 8955–8971. Retrieved from https://doi.org/10.1021/jm400856t doi:10.1021/jm400856t
   PubMed Web of Science ®Google Scholar
• Powers, A. D., & Oltmanns, T. F. (2013). Borderline personality pathology and chronic health problems in later adulthood: The mediating role of obesity. Personality Disorders: Theory, Research, and Treatment, 4, 152–159. doi:10.1037/a0028709
   Web of Science ®Google Scholar
• Renneberg, B., Schmitz, B., Doering, S., Herpertz, S. C., & Bohus, M. (2010). Leitlinienkommission-Persönlichkeitsstörungen Behandlungsleitlinie Persönlichkeitsstörungen. Psychotherapeut, 55, 339–354. doi:10.1007/s00278-010-0748-5
   Google Scholar
• Richardson, J. T. E. (2011). Eta squared and partial eta squared as measures of effect size in educational research. Educational Research Review, 6, 135–147. doi:10.1016/j.edurev.2010.12.001
   Web of Science ®Google Scholar
• Riffer, F., Kaiser, E., & Fellinger, B. (2016). Stationäre Therapie psychosomatischer Erkrankungen-ein Modell für Österreich. JATROS Neurologie & Psychiatrie, 24, 38–40.
   Google Scholar
• Silk, K. R. (2015). Management and effectiveness of psychopharmacology in emotionally unstable and borderline personality disorder. The Journal of Clinical Psychiatry, 76, 524–525. doi:10.4088/JCP.14com09534
   PubMed Web of Science ®Google Scholar
• Soloff, P. H. (1998). Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation. Bulletin of the Menninger Clinic, 62, 195–214.
   PubMed Web of Science ®Google Scholar
• Soloff, P. H. (2000). Psychopharmacology of borderline personality disorder. Psychiatric Clinics of North America, 23, 169–192. Retrieved from http://www.sciencedirect.com/science/article/pii/S0193953X05701507 doi:10.1016/S0193-953X(05)70150-7
   PubMed Web of Science ®Google Scholar
• Starcevic, V., & Janca, A. (2018). Pharmacotherapy of borderline personality disorder: replacing confusion with prudent pragmatism. Current Opinions in Psychiatry, 31, 69–73. doi:10.1097/YCO.0000000000000373
   PubMed Web of Science ®Google Scholar
• Torgersen, S., Kringlen, E., & Cramer, V. (2001). The prevalence of personality disorders in a community sample. Archives of General Psychiatry, 58, 590–596. doi:10.1001/archpsyc.58.6.590
   PubMed Web of Science ®Google Scholar
• Tyrer, P., & Silk, K. R. (2011). A comparison of UK and US guidelines for drug treatment in borderline personality disorder. International Review of Psychiatry, 23, 388–394. doi:10.3109/09540261.2011.606540
   PubMed Web of Science ®Google Scholar
• Vita, A., De Peri, L., & Sacchetti, E. (2011). Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: A meta-analysis of randomized controlled and open-label trials. Journal of Clinical Psychopharmacology, 31, 613–624. doi:10.1097/JCP.0b013e31822c1636
   PubMed Web of Science ®Google Scholar
• Widom, C. S., Czaja, S. J., & Paris, J. (2009). A prospective investigation of borderline personality disorder in abused and neglected children followed up into adulthood. Journal of Personality Disorders, 23, 433–446. doi:10.1521/pedi.2009.23.5.433
   PubMed Web of Science ®Google Scholar
• Winsper, C. (2018). The aetiology of borderline personality disorder (BPD): contemporary theories and putative mechanisms. Current Opinion in Psychology, 21, 105–110. doi:10.1016/j.copsyc.2017.10.005
   PubMed Web of Science ®Google Scholar
• Witt, S. H., Streit, F., Jungkunz, M., Frank, J., Awasthi, S., Reinbold, C. S., … Rietschel, M. (2017). Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Translational Psychiatry, 7, e1155. doi:10.1038/tp.2017.115
   PubMed Web of Science ®Google Scholar
• World-Health-Organization. (1992). The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva, Switzerland: World Health Organization.
   Google Scholar
• Zanarini, M. C., Frankenburg, F. R., Hennen, J., Reich, D. B., & Silk, K. R. (2006). Prediction of the 10-year course of borderline personality disorder. American Journal of Psychiatry, 163, 827–832. doi:10.1176/ajp.2006.163.5.827
   PubMed Web of Science ®Google Scholar
• Zanarini, M. C., Frankenburg, F. R., Hennen, J., & Silk, K. R. (2004). Mental health service utilization by borderline personality disorder patients and axis ii comparison subjects followed prospectively for 6 years. The Journal of Clinical Psychiatry, 65, 28–36. doi:10.4088/JCP.v65n0105
   PubMed Web of Science ®Google Scholar
• Zanarini, M. C., Frankenburg, F. R., Reich, D. B., Silk, K. R., Hudson, J. I., & McSweeney, L. B. (2007). The subsyndromal phenomenology of borderline personality disorder: A 10-year follow-up study. American Journal of Psychiatry, 164, 929–935. doi:10.1176/ajp.2007.164.6.929
   PubMed Web of Science ®Google Scholar
• Zanarini, M. C., Reichman, C. A., Frankenburg, F. R., Reich, D. B., & Fitzmaurice, G. (2010). The course of eating disorders in patients with borderline personality disorder: A 10-year follow-up study. The International Journal of Eating Disorders, 43, 226–232. doi:10.1002/eat.20689
   PubMed Web of Science ®Google Scholar
• Zimmerman, M., Rothschild, L., & Chelminski, I. (2005). The prevalence of DSM-IV personality disorders in psychiatric outpatients. American Journal of Psychiatry, 162, 1911–1918. doi:10.1176/appi.ajp.162.10.1911
   PubMed Web of Science ®Google Scholar